Figure 2 | Scientific Reports

Figure 2

From: Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer

Figure 2

Serum Shh and IL-6 significantly differ between normal and cancer patients. (A) Serum and plasma Shh and IL-6 levels from healthy volunteers, early operable and untreated progressive metastatic breast cancer patients. (B) Serum Shh and IL-6 levels from early operable patients before and after surgery, as well as before and after chemotherapy from untreated progressive metastatic patients. (C) ROC curves of serum Shh and IL-6 as predictors in progressive metastatic breast cancer patients.

Back to article page